查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1933954

聚焦超音波消融手術市場：按技術、工作流程、系統類型、患者年齡層、應用和最終用戶分類－全球預測，2026-2032年

Focused Ultrasound Ablation Surgery Market by Technology, Workflow, System Type, Patient Age Group, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 198 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，聚焦超音波消融手術市場價值將達到 30.1 億美元，到 2026 年將成長至 32.6 億美元，到 2032 年將達到 58.1 億美元，複合年成長率為 9.84%。

關鍵市場統計數據
基準年 2025 30.1億美元
預計年份：2026年 32.6億美元
預測年份 2032 58.1億美元
複合年成長率 (%) 9.84%

影像引導能量傳輸和不斷發展的臨床通訊協定如何改變聚焦超音波消融術在專科領域的應用路徑

聚焦超音波消融術已從一項實驗性介入措施發展成為多個臨床專科的主流治療方法。該技術結合了精確的能量傳遞和影像引導，可實現非侵入性或微創組織消融，在減少手術全期併發症、縮短恢復時間和建立門診治療路徑方面展現出良好的臨床應用前景。在神經病學領域，熱消融和神經調控方法正不斷改進，以毫米級的精度靶向深部腦部結構，用於治療運動障礙和難治性癲癇。在腫瘤學領域，熱消融和機械消融技術正被探索作為局部腫瘤的器官保留治療方案或作為全身性治療的輔助手段。

關鍵的顛覆性趨勢和技術進步將加速聚焦超音波消融術的臨床應用，轉變治療路徑，並改變該領域的競爭格局。

聚焦超音波消融領域正經歷變革性的轉變，這主要得益於技術進步、臨床證據的不斷累積以及醫療服務體系所面臨的壓力。成像精度的提高和即時溫度測量的改進增強了操作者的信心，使得該技術得以從單一適應症的試點研究擴展到多學科聯合計畫。同時，模組化系統結構和可攜式配置縮小了手術空間，提高了手術效率，從而支持了向門診模式的過渡。在神經病學領域，更精確的標靶演算法和神經導航工具的整合正在拓展運動障礙的適應症，使其不再局限於自發性震顫。同時，腫瘤科團隊正在嘗試將消融療法與免疫調節療法結合的聯合治療。

2025年關稅調整如何重塑聚焦超音波設備相關人員的全球供應鏈、資本配置決策與採購風險評估

美國將於2025年實施的關稅調整，將為聚焦超音波技術領域的製造商、經銷商和醫療服務提供者帶來更複雜的商業環境。關稅調整提高了進口零件和整機的到岸成本，尤其是高精度換能器組件、高頻電子元件以及某些通常從全球供應商採購的成像子系統。因此，製造商被迫重新評估其供應鏈結構，優先考慮在地採購策略，並與供應商協商能夠降低成本波動的合約。

一個分層細分框架，用於識別臨床適應症、指導技術、臨床環境、工作流程、系統結構和患者人口統計特徵如何定義差異化的價值提案。

我們的細分市場分析表明，聚焦超音波消融技術與廣泛的臨床應用、引導技術、醫療環境、工作流程、硬體架構和患者群體交織，從而為每個細分市場創造了差異化的價值提案。神經內科涵蓋腦腫瘤治療、癲癇控制、自發性震顫緩解和帕金森氏症症狀控制。腫瘤科涵蓋腎癌、肝癌、胰臟癌和前列腺癌的標靶治療。泌尿科治療良性前列腺增生和腎結石，而泌尿系統專注於子宮肌腺症和子宮肌瘤。從技術面來看，MRI引導系統分為封閉式和開放式兩種配置，分別著重於不同的影像權衡。超音波引導系統根據入路方式和聚焦超音波需求，區分腔內和體外兩種方法。最終使用者細分包括醫院所屬和獨立的門診手術中心、包括公立和私立醫院在內的各類醫院，以及由學術機構和私人公司組成的研究機構。每個醫療機構都有其自身的資本投資核准流程和臨床試驗要求。住院和門診病人工作流程的差異（門診又細分為日間手術和診室手術）會影響設備選擇、手術室設計和人員配置模式。多元素架構和單元素架構之間的系統類型差異會影響成本、焦點控制和臨床適應性。此外，患者年齡層分類區分成人和兒童，成人患者進一步細分為老年和非老年患者，反映了不同的合併症情況和手術全期耐受性。了解這些相互交織的層面有助於更精準的臨床定位、客製化的培訓計劃以及反映每種臨床和營運環境細微需求的報銷策略。

區域醫療保健基礎設施、報銷途徑和生產策略如何推動美洲、歐洲、中東和非洲以及亞太地區不同的採用模式

區域趨勢正在影響聚焦超音波消融系統的採用、資金籌措和應用規模。在美洲，對門診醫療基礎設施的投資以及對微創替代方案日益成長的需求，正推動醫院系統和日間手術中心試點開展整合計畫。密集的私人醫療機構網路正在支持該手術在大都會圈市場的快速普及。歐洲、中東和非洲的情況則較為複雜，監管協調、公立醫院採購週期以及不同的報銷政策都會影響該手術的普及速度。在一些國家，集中化的衛生技術評估流程和國家臨床網路正在加速實證醫學證據的產生和傳播。在亞太地區，手術量的成長、私立醫院容量的擴大以及積極的本地化生產舉措是強勁成長要素，部分市場優先考慮技術轉移和國內生產以應對成本壓力。

策略競爭措施、臨床夥伴關係模式和服務生態系統決定了市場領導地位和供應商與醫療服務提供者之間的長期關係。

聚焦超音波消融領域的競爭力取決於臨床證據的領先地位、系統的多功能性、完善的服務和培訓體係以及商業性夥伴關係關係。領先的製造商致力於建立強大的臨床試驗管線，以證明其在多種適應症中的安全性和有效性，同時投資於模組化硬體和軟體升級，從而在無需更換整個系統的情況下逐步提升功能。與影像設備供應商和學術機構的策略聯盟正在加速真實世界數據的收集，並為研究者發起的、能夠為指南制定提供主導的研究鋪平道路。

製造商、臨床專案經理和支付方為加速產品推廣、確保採購和降低供應鏈風險而必須採取的實際策略措施

行業領導者應採取一系列合作措施，將臨床潛力轉化為永續的商業性成功。首先，將產品藍圖與優先臨床應用案例相匹配，集中研發資源於能夠顯著降低醫院資源利用率並改善以患者為中心的治療效果的適應症。其次，投資於可擴展的培訓課程和指導項目，以降低社區醫院和門診手術中心採用該產品的門檻，同時收集手術數據以檢驗療效。第三，透過多元化採購來源、認證本地供應商以及增加備件庫存來增強供應鏈韌性，從而最大限度地減少貿易政策變化對臨床營運的干擾。第四，發展靈活的商業模式，包括資本租賃、按績效付費合約和綜合服務包，以滿足公立和私立醫院的採購需求。

我們採用了嚴謹的混合調查方法，結合了相關人員訪談、臨床證據綜合、供應鏈映射和交叉檢驗，以支持可操作的策略指導。

本分析的調查方法結合了與關鍵相關人員的直接對話、結構化的二手檢驗綜合和三角驗證，以確保其穩健的有效性和相關性。主要研究包括對神經內科、腫瘤科、泌尿系統和婦科的臨床負責人進行深度訪談；與門診手術中心和醫院的採購和運營總監進行討論；以及諮詢監管和報銷專家，以了解區域決策框架。二手研究涵蓋了同行評審的臨床文獻、臨床試驗註冊資訊、醫療設備標籤和核准文件、專利申請以及行業媒體關於策略聯盟和產品發布的報告。供應鏈評估整合了供應商分佈圖、進口關稅和分銷模式，以識別潛在的瓶頸和緩解策略。

整合臨床、商業性和營運方面的決定因素，以確定聚焦超音波消融術能否充分發揮其潛力，從而改變手術醫學的實施方式。

聚焦超音波消融術正處於臨床成熟度和商業性可行性交會的轉折點，為醫療系統提供了一條降低手術創傷、提高患者周轉率的途徑。神經內科、腫瘤科、泌尿系統和婦科等領域的推廣應用，得益於影像導引、換能器技術以及門診友善手術流程的不斷改進。然而，其廣泛應用將受到許多實際因素的影響，例如設備互通性、臨床醫生培訓、報銷機制以及在貿易政策變化下供應鏈的韌性。

目錄

第1章：序言

第2章調查方法

  • 研究設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查前提
  • 調查限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 市場進入策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會地圖
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

8. 按技術分類的聚焦超音波消融手術市場

  • 磁共振引導
    • 封閉式
    • 開放型
  • 超音波引導
    • 管腔內
    • 體外

9. 依工作流程分類的聚焦超音波消融手術市場

  • 住院病人
  • 門診
    • 日間手術
    • 門診手術

第10章 依系統類型分類的聚焦超音波消融手術市場

  • 多元素
  • 單元素

第11章 依患者年齡層分類的聚焦超音波消融手術市場

  • 成人版
    • 老年人
    • 非老年人
  • 兒童

第12章 聚焦超音波消融手術市場（依應用領域分類）

  • 神經病學
    • 腦腫瘤
    • 癲癇
    • 自發性震顫
    • 帕金森氏症
  • 腫瘤學
    • 腎癌
    • 肝癌
    • 胰臟癌
    • 攝護腺癌
  • 泌尿系統
    • 良性攝護腺增生
    • 腎結石
  • 婦科領域
    • 子宮肌腺症
    • 子宮肌瘤

第13章 聚焦超音波消融手術市場（依最終用戶分類）

  • 門診手術中心
    • 醫院所屬中心
    • 獨立中心
  • 醫院
    • 私立醫院
    • 公立醫院
  • 研究所
    • 學術機構
    • 私立機構

14. 各地區聚焦超音波消融手術市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第15章 聚焦超音波消融手術市場（按組別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第16章 各國聚焦超音波消融手術市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第17章：美國聚焦超音波消融手術市場

第18章：中國聚焦超音波消融手術市場

第19章 競爭情勢

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Alpinion Medical Systems Co Ltd
  • Blatek Industries Inc
  • Boston Scientific Corporation
  • Changjiangyuan Technology Development Co Ltd
  • Chongqing Haifu Medical Equipment Co., Ltd.
  • EDAP TMS SA
  • FUS Foundation
  • GE HealthCare Technologies Inc
  • HistoSonics, Inc.
  • Hitachi, Ltd.
  • Hologic Inc
  • Image Guided Therapy SA
  • Insightec Ltd.
  • Koninklijke Philips NV
  • Medtronic plc
  • Profound Medical Corp.
  • Samsung Medison Co Ltd
  • Shanghai A&S Technology Development Co Ltd
  • Siemens Healthineers AG
  • Sonablate Corp
  • SonaCare Medical LLC
  • Supersonic Imagine SA
  • Theraclion SA
  • Thermogrid Technologies Inc
  • Wikkon Medical Technology Co Ltd
  • ZONARE Medical Systems Inc
Product Code: MRR-C36616F69ABB

The Focused Ultrasound Ablation Surgery Market was valued at USD 3.01 billion in 2025 and is projected to grow to USD 3.26 billion in 2026, with a CAGR of 9.84%, reaching USD 5.81 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 3.01 billion
Estimated Year [2026] USD 3.26 billion
Forecast Year [2032] USD 5.81 billion
CAGR (%) 9.84%

How the evolution of image-guided energy delivery and clinical protocols is reshaping adoption pathways for focused ultrasound ablation across specialty care settings

Focused ultrasound ablation has evolved from experimental interventions to an increasingly mainstream therapeutic modality across multiple clinical specialties. The technology couples precise energy delivery with image guidance to create noninvasive or minimally invasive tissue ablation, and its clinical promise lies in reducing perioperative morbidity, shortening recovery times, and enabling outpatient care pathways. In neurology, thermal ablation and neuromodulation approaches are being refined to target deep brain structures with millimetric precision for movement disorders and refractory epilepsy. In oncology, thermal and mechanical ablation techniques are being explored as organ-preserving alternatives or adjuncts to systemic therapy for focal tumors.

Concurrently, advances in imaging and transducer design have expanded procedural safety and expanded indications. The convergence of improved guidance platforms, enhanced thermal monitoring, and shorter procedural footprints is enabling broader adoption by hospitals, ambulatory surgical centers, and research institutes. Moreover, the maturation of standardized clinical protocols and the accumulation of medium-term outcome data have begun to shape payer conversations and hospital investment decisions. As clinicians and administrators weigh capital and operational choices, implementation strategies that align technology capability with institutional workflow and patient selection criteria are becoming paramount, guiding how programs scale and integrate focused ultrasound into standard care.

Key disruptive trends and technological improvements that are accelerating clinical adoption, altering care pathways, and shifting competitive imperatives in focused ultrasound ablation

The landscape for focused ultrasound ablation is undergoing transformative shifts driven by technological refinement, clinical evidence accumulation, and systemic pressures on healthcare delivery. Improved imaging fidelity and real-time thermometry have increased operator confidence, enabling expansion from single-indication pilots to multi-specialty programs. At the same time, modular system architectures and portable configurations are reducing procedural footprint and enabling greater procedural throughput, which in turn supports outpatient migration. In neurology, the refinement of targeting algorithms and the integration of neuro-navigation tools have broadened suitability for movement disorders beyond essential tremor, while oncology teams are experimenting with combination regimens that pair ablation with immunomodulatory approaches.

Parallel forces are influencing commercial dynamics. Providers are prioritizing capital that supports ambulatory and hybrid care models, creating demand for devices that demonstrate efficient workflow integration and predictable operating profiles. Research institutes and private centers are catalyzing adoption by generating comparative effectiveness evidence and hosting investigator-initiated studies. Finally, the shifting reimbursement landscape and greater emphasis on value-based outcomes are privileging technologies that demonstrably reduce length of stay, lower complication rates, and enable same-day discharge, thereby accelerating adoption in resource-constrained care environments.

How 2025 tariff adjustments are reshaping global supply chains, capital deployment decisions, and procurement risk assessments for focused ultrasound device stakeholders

United States tariff changes introduced in 2025 have created a more complex commercial environment for manufacturers, distributors, and healthcare providers engaged with focused ultrasound technologies. Tariff adjustments have increased landed costs for imported components and finished systems, particularly for high-precision transducer assemblies, RF electronics, and certain imaging subsystems that are commonly sourced from global suppliers. As a result, manufacturers have been prompted to reassess supply chain structures, prioritize local content strategies, and negotiate supplier agreements that mitigate cost volatility.

Clinicians and hospital procurement teams have felt downstream effects through extended lead times and periodic component shortages, which have in some instances delayed installation timelines for capital equipment. Moreover, the tariff environment has sharpened attention on total cost of ownership, including service contracts and consumable pricing, which influences procurement committees' vendor selection criteria. In response, several device makers have expanded regional repair centers, increased local inventory buffers, and accelerated partnerships with domestic suppliers to preserve pricing competitiveness and protect clinical uptime. These adaptive measures, together with proactive contracting strategies by providers, are serving to reduce disruption while reshaping how organizations evaluate vendor resilience and long-term partnership value.

A layered segmentation framework revealing how clinical indication, guidance technology, care setting, workflow, system architecture, and patient demographics define differentiated value propositions

Segmentation analysis reveals that focused ultrasound ablation technologies intersect a broad matrix of clinical applications, guidance modalities, care settings, workflows, hardware architectures, and patient populations, creating differentiated value propositions for each market segment. Within applications, neurology spans brain tumor management, epilepsy control, essential tremor relief, and Parkinson disease symptom modulation, while oncology encompasses focal treatments for kidney, liver, pancreatic, and prostate cancers. Urology applications address benign prostatic hyperplasia and kidney stones, and women's health focuses on adenomyosis and uterine fibroids. From a technology perspective, MRI-guided systems bifurcate into closed bore and open bore configurations that prioritize different imaging trade-offs, and ultrasound-guided systems differentiate between endoluminal and extracorporeal approaches based on access and focal depth requirements. End user segmentation includes ambulatory surgical centers that may be hospital-owned or standalone, hospitals that include private and public institutions, and research institutes composed of academic and private entities, each with distinct capital approval processes and clinical trial imperatives. Workflow distinctions between inpatient and outpatient care, with outpatient further subdivided into daycare surgery and office-based surgery, influence device selection, room design, and staffing models. System type considerations between multi-element and single-element architectures drive cost, focal control, and clinical versatility. Finally, patient age group segmentation differentiates adult and pediatric populations, with adult care further stratified by elderly and non-elderly cohorts to reflect differing comorbidity profiles and perioperative tolerance. Understanding these intersecting layers enables more precise clinical positioning, tailored training programs, and reimbursement strategies that reflect the nuanced needs of each clinical and operational context.

How regional healthcare infrastructure, reimbursement pathways, and manufacturing strategies are driving differentiated adoption patterns across the Americas, Europe Middle East & Africa, and Asia-Pacific

Regional dynamics are shaping where and how focused ultrasound ablation systems are adopted, funded, and scaled. In the Americas, investment in outpatient infrastructure and a growing appetite for minimally invasive alternatives have incentivized hospital systems and ambulatory surgery centers to pilot integrated programs, while a dense private provider network supports rapid procedural diffusion across metropolitan markets. Europe, the Middle East & Africa present a heterogeneous landscape where regulatory harmonization, public hospital procurement cycles, and variable reimbursement policies influence adoption tempo; in several countries, centralized health technology assessment processes and national clinical networks have accelerated evidence generation and dissemination. Asia-Pacific exhibits strong growth drivers tied to rising procedural volumes, expanding private hospital capacity, and proactive local manufacturing initiatives, with some markets prioritizing technology transfer and domestic production to manage cost pressures.

Across regions, common themes emerge: the need for context-specific training pathways, the importance of aligning device capabilities with facility workflows, and the value of robust clinical evidence to support reimbursement negotiations. Consequently, successful regional strategies anticipate regulatory timelines, invest in local key opinion leader engagement, and design distribution models that reflect the operational realities of hospitals, ambulatory centers, and research institutes in each geography.

Strategic competitive behaviors, clinical partnership models, and service ecosystems that determine market leadership and long-term vendor-institution relationships

Competitive dynamics in focused ultrasound ablation are defined by a combination of clinical evidence leadership, system versatility, service and training ecosystems, and commercial partnerships. Leading manufacturers have focused on building robust clinical pipelines that demonstrate safety and efficacy across multiple indications, while also investing in modular hardware and software upgrades that enable incremental capability expansion without full-system replacement. Strategic alliances with imaging vendors and academic centers have accelerated real-world data collection and created pathways for investigator-initiated studies that inform guideline development.

Service models have become a competitive differentiator; organizations that combine device sales with comprehensive training programs, local maintenance networks, and outcome tracking platforms are more likely to secure long-term institutional partnerships. Additionally, aftermarket revenue streams from consumables, software licenses, and procedure-specific disposables are increasingly important to financial models. Partnerships between device manufacturers and hospital networks or ambulatory surgical groups have also emerged, facilitating pilot programs and bundled purchasing agreements. Finally, intellectual property portfolios and regulatory track records matter: companies with cleared device claims across multiple indications and geographies can leverage those credentials to accelerate adoption and negotiate favorable procurement terms with large health systems.

Actionable strategic imperatives for manufacturers, clinical program leaders, and payers to accelerate adoption, secure procurement, and de-risk supply chain exposure

Industry leaders should pursue a set of coordinated actions to convert clinical promise into sustainable commercial performance. First, align product roadmaps with prioritized clinical use cases by concentrating development resources on indications that offer clear reductions in hospital resource utilization and improved patient-centric outcomes. Second, invest in scalable training curricula and proctoring programs that lower the adoption barrier for community hospitals and ambulatory surgical centers, while simultaneously capturing procedural data for outcomes validation. Third, strengthen supply chain resilience by diversifying sourcing, qualifying regional suppliers, and increasing spare parts inventories to minimize clinical disruptions from trade policy shifts. Fourth, develop flexible commercial models that include capital leases, outcome-based contracting, and bundled service packages to address procurement preferences across public and private hospitals.

Moreover, foster payer engagement early by generating cost-effectiveness evidence and real-world outcome datasets that demonstrate reduced length of stay and complication rates. Engage in targeted regional strategies by partnering with local manufacturing or service providers where tariffs or logistic challenges pressure total cost of ownership. Finally, prioritize interoperability and software-driven service offerings that enable remote monitoring, predictive maintenance, and outcomes tracking, thereby creating recurring revenue streams and deepening client relationships.

A rigorous mixed-method research approach combining stakeholder interviews, clinical evidence synthesis, supply chain mapping, and cross-validation to support actionable strategic guidance

The research methodology underpinning this analysis combined primary stakeholder engagement with structured secondary evidence synthesis and triangulation to ensure robustness and relevance. Primary research included in-depth interviews with clinical leaders across neurology, oncology, urology, and women's health, discussions with procurement and operations executives from ambulatory surgical centers and hospitals, and consultations with regulatory and reimbursement specialists to understand regional decision frameworks. Secondary research encompassed peer-reviewed clinical literature, clinical trial registries, device labeling and clearance documents, patent filings, and industry press that highlights strategic partnerships and product launches. Supply chain assessments integrated supplier mapping, import tariff schedules, and distributor models to identify potential bottlenecks and mitigation pathways.

Data were synthesized using a cross-validation approach that reconciled clinician perspectives, commercial intelligence, and regulatory context. Where evidence gaps existed, scenario-based analysis was used to articulate plausible operational impacts and strategic responses. The methodology prioritized transparency, noting the provenance of primary insights and the limitations of indirect evidence, and emphasized actionable conclusions designed to inform procurement decisions, clinical program design, and strategic investment prioritization.

Synthesis of clinical, commercial, and operational determinants that will govern whether focused ultrasound ablation fulfills its potential to transform procedural care delivery

Focused ultrasound ablation stands at an inflection point where clinical maturity and commercial viability intersect, offering health systems a pathway to reduce procedural invasiveness and enhance patient throughput. The technology's expansion across neurology, oncology, urology, and women's health is supported by iterative improvements in imaging guidance, transducer technology, and procedural workflows that favor outpatient care. Nevertheless, adoption will be mediated by pragmatic considerations including device interoperability, clinician training, reimbursement alignment, and supply chain resilience in the face of trade policy shifts.

Strategic success will accrue to organizations that align product development with high-value clinical use cases, invest in scalable training and service ecosystems, and engage payers with robust real-world evidence. Regional strategies that account for regulatory heterogeneity and manufacturing localization will further reduce procurement friction. In short, focused ultrasound ablation can meaningfully alter clinical pathways and institutional economics, but realizing that potential requires coordinated action across clinical, commercial, and operational dimensions.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Focused Ultrasound Ablation Surgery Market, by Technology

  • 8.1. Mri Guided
    • 8.1.1. Closed Bore
    • 8.1.2. Open Bore
  • 8.2. Ultrasound Guided
    • 8.2.1. Endoluminal
    • 8.2.2. Extracorporeal

9. Focused Ultrasound Ablation Surgery Market, by Workflow

  • 9.1. Inpatient
  • 9.2. Outpatient
    • 9.2.1. Daycare Surgery
    • 9.2.2. Office Based Surgery

10. Focused Ultrasound Ablation Surgery Market, by System Type

  • 10.1. Multi Element
  • 10.2. Single Element

11. Focused Ultrasound Ablation Surgery Market, by Patient Age Group

  • 11.1. Adult
    • 11.1.1. Elderly
    • 11.1.2. Non Elderly
  • 11.2. Pediatric

12. Focused Ultrasound Ablation Surgery Market, by Application

  • 12.1. Neurology
    • 12.1.1. Brain Tumor
    • 12.1.2. Epilepsy
    • 12.1.3. Essential Tremor
    • 12.1.4. Parkinson Disease
  • 12.2. Oncology
    • 12.2.1. Kidney Cancer
    • 12.2.2. Liver Cancer
    • 12.2.3. Pancreatic Cancer
    • 12.2.4. Prostate Cancer
  • 12.3. Urology
    • 12.3.1. Benign Prostatic Hyperplasia
    • 12.3.2. Kidney Stones
  • 12.4. Women Health
    • 12.4.1. Adenomyosis
    • 12.4.2. Uterine Fibroids

13. Focused Ultrasound Ablation Surgery Market, by End User

  • 13.1. Ambulatory Surgical Centers
    • 13.1.1. Hospital Owned Centers
    • 13.1.2. Standalone Centers
  • 13.2. Hospitals
    • 13.2.1. Private Hospitals
    • 13.2.2. Public Hospitals
  • 13.3. Research Institutes
    • 13.3.1. Academic Institutes
    • 13.3.2. Private Institutes

14. Focused Ultrasound Ablation Surgery Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Focused Ultrasound Ablation Surgery Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Focused Ultrasound Ablation Surgery Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. United States Focused Ultrasound Ablation Surgery Market

18. China Focused Ultrasound Ablation Surgery Market

19. Competitive Landscape

  • 19.1. Market Concentration Analysis, 2025
    • 19.1.1. Concentration Ratio (CR)
    • 19.1.2. Herfindahl Hirschman Index (HHI)
  • 19.2. Recent Developments & Impact Analysis, 2025
  • 19.3. Product Portfolio Analysis, 2025
  • 19.4. Benchmarking Analysis, 2025
  • 19.5. Alpinion Medical Systems Co Ltd
  • 19.6. Blatek Industries Inc
  • 19.7. Boston Scientific Corporation
  • 19.8. Changjiangyuan Technology Development Co Ltd
  • 19.9. Chongqing Haifu Medical Equipment Co., Ltd.
  • 19.10. EDAP TMS S.A.
  • 19.11. FUS Foundation
  • 19.12. GE HealthCare Technologies Inc
  • 19.13. HistoSonics, Inc.
  • 19.14. Hitachi, Ltd.
  • 19.15. Hologic Inc
  • 19.16. Image Guided Therapy S.A.
  • 19.17. Insightec Ltd.
  • 19.18. Koninklijke Philips N.V.
  • 19.19. Medtronic plc
  • 19.20. Profound Medical Corp.
  • 19.21. Samsung Medison Co Ltd
  • 19.22. Shanghai A&S Technology Development Co Ltd
  • 19.23. Siemens Healthineers AG
  • 19.24. Sonablate Corp
  • 19.25. SonaCare Medical LLC
  • 19.26. Supersonic Imagine SA
  • 19.27. Theraclion S.A.
  • 19.28. Thermogrid Technologies Inc
  • 19.29. Wikkon Medical Technology Co Ltd
  • 19.30. ZONARE Medical Systems Inc

LIST OF FIGURES

  • FIGURE 1. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY WORKFLOW, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY SYSTEM TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY PATIENT AGE GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. UNITED STATES FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 14. CHINA FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY MRI GUIDED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY MRI GUIDED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY MRI GUIDED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY MRI GUIDED, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY CLOSED BORE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY CLOSED BORE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY CLOSED BORE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY OPEN BORE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY OPEN BORE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY OPEN BORE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY ULTRASOUND GUIDED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY ULTRASOUND GUIDED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY ULTRASOUND GUIDED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY ULTRASOUND GUIDED, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY ENDOLUMINAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY ENDOLUMINAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY ENDOLUMINAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY EXTRACORPOREAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY EXTRACORPOREAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY EXTRACORPOREAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY WORKFLOW, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY INPATIENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY INPATIENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY INPATIENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY OUTPATIENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY OUTPATIENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY OUTPATIENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY OUTPATIENT, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY DAYCARE SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY DAYCARE SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY DAYCARE SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY OFFICE BASED SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY OFFICE BASED SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY OFFICE BASED SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY MULTI ELEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY MULTI ELEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY MULTI ELEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY SINGLE ELEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY SINGLE ELEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY SINGLE ELEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY ADULT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY ADULT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY ADULT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY ADULT, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY ELDERLY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY ELDERLY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY ELDERLY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY NON ELDERLY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY NON ELDERLY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY NON ELDERLY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY PEDIATRIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY PEDIATRIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY NEUROLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY NEUROLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY BRAIN TUMOR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY BRAIN TUMOR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY BRAIN TUMOR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY EPILEPSY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY EPILEPSY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY EPILEPSY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY ESSENTIAL TREMOR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY ESSENTIAL TREMOR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY ESSENTIAL TREMOR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY PARKINSON DISEASE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY PARKINSON DISEASE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY PARKINSON DISEASE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY ONCOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY KIDNEY CANCER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY KIDNEY CANCER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY KIDNEY CANCER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY LIVER CANCER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY LIVER CANCER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY LIVER CANCER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY PANCREATIC CANCER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY PANCREATIC CANCER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY PANCREATIC CANCER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY PROSTATE CANCER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY PROSTATE CANCER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY UROLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY UROLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY UROLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY UROLOGY, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY BENIGN PROSTATIC HYPERPLASIA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY BENIGN PROSTATIC HYPERPLASIA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY BENIGN PROSTATIC HYPERPLASIA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY KIDNEY STONES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY KIDNEY STONES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY KIDNEY STONES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY WOMEN HEALTH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY WOMEN HEALTH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY WOMEN HEALTH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY WOMEN HEALTH, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY ADENOMYOSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY ADENOMYOSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY ADENOMYOSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY UTERINE FIBROIDS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY UTERINE FIBROIDS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY UTERINE FIBROIDS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY HOSPITAL OWNED CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY HOSPITAL OWNED CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY HOSPITAL OWNED CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY STANDALONE CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY STANDALONE CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY STANDALONE CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY PRIVATE HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY PRIVATE HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY PUBLIC HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY PUBLIC HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 136. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY ACADEMIC INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY ACADEMIC INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 138. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY ACADEMIC INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 139. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY PRIVATE INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 140. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY PRIVATE INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 141. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY PRIVATE INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 142. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 143. AMERICAS FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 144. AMERICAS FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 145. AMERICAS FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY MRI GUIDED, 2018-2032 (USD MILLION)
  • TABLE 146. AMERICAS FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY ULTRASOUND GUIDED, 2018-2032 (USD MILLION)
  • TABLE 147. AMERICAS FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY WORKFLOW, 2018-2032 (USD MILLION)
  • TABLE 148. AMERICAS FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY OUTPATIENT, 2018-2032 (USD MILLION)
  • TABLE 149. AMERICAS FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 150. AMERICAS FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 151. AMERICAS FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY ADULT, 2018-2032 (USD MILLION)
  • TABLE 152. AMERICAS FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 153. AMERICAS FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 154. AMERICAS FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 155. AMERICAS FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY UROLOGY, 2018-2032 (USD MILLION)
  • TABLE 156. AMERICAS FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY WOMEN HEALTH, 2018-2032 (USD MILLION)
  • TABLE 157. AMERICAS FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 158. AMERICAS FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 159. AMERICAS FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 160. AMERICAS FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 161. NORTH AMERICA FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 162. NORTH AMERICA FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 163. NORTH AMERICA FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY MRI GUIDED, 2018-2032 (USD MILLION)
  • TABLE 164. NORTH AMERICA FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY ULTRASOUND GUIDED, 2018-2032 (USD MILLION)
  • TABLE 165. NORTH AMERICA FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY WORKFLOW, 2018-2032 (USD MILLION)
  • TABLE 166. NORTH AMERICA FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY OUTPATIENT, 2018-2032 (USD MILLION)
  • TABLE 167. NORTH AMERICA FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 168. NORTH AMERICA FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 169. NORTH AMERICA FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY ADULT, 2018-2032 (USD MILLION)
  • TABLE 170. NORTH AMERICA FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 171. NORTH AMERICA FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 172. NORTH AMERICA FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 173. NORTH AMERICA FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY UROLOGY, 2018-2032 (USD MILLION)
  • TABLE 174. NORTH AMERICA FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY WOMEN HEALTH, 2018-2032 (USD MILLION)
  • TABLE 175. NORTH AMERICA FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 176. NORTH AMERICA FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 177. NORTH AMERICA FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 178. NORTH AMERICA FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 179. LATIN AMERICA FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 180. LATIN AMERICA FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 181. LATIN AMERICA FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY MRI GUIDED, 2018-2032 (USD MILLION)
  • TABLE 182. LATIN AMERICA FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY ULTRASOUND GUIDED, 2018-2032 (USD MILLION)
  • TABLE 183. LATIN AMERICA FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY WORKFLOW, 2018-2032 (USD MILLION)
  • TABLE 184. LATIN AMERICA FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY OUTPATIENT, 2018-2032 (USD MILLION)
  • TABLE 185. LATIN AMERICA FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 186. LATIN AMERICA FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 187. LATIN AMERICA FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY ADULT, 2018-2032 (USD MILLION)
  • TABLE 188. LATIN AMERICA FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 189. LATIN AMERICA FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 190. LATIN AMERICA FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 191. LATIN AMERICA FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY UROLOGY, 2018-2032 (USD MILLION)
  • TABLE 192. LATIN AMERICA FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY WOMEN HEALTH, 2018-2032 (USD MILLION)
  • TABLE 193. LATIN AMERICA FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 194. LATIN AMERICA FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 195. LATIN AMERICA FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 196. LATIN AMERICA FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 197. EUROPE, MIDDLE EAST & AFRICA FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 198. EUROPE, MIDDLE EAST & AFRICA FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 199. EUROPE, MIDDLE EAST & AFRICA FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY MRI GUIDED, 2018-2032 (USD MILLION)
  • TABLE 200. EUROPE, MIDDLE EAST & AFRICA FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY ULTRASOUND GUIDED, 2018-2032 (USD MILLION)
  • TABLE 201. EUROPE, MIDDLE EAST & AFRICA FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY WORKFLOW, 2018-2032 (USD MILLION)
  • TABLE 202. EUROPE, MIDDLE EAST & AFRICA FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY OUTPATIENT, 2018-2032 (USD MILLION)
  • TABLE 203. EUROPE, MIDDLE EAST & AFRICA FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 204. EUROPE, MIDDLE EAST & AFRICA FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 205. EUROPE, MIDDLE EAST & AFRICA FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY ADULT, 2018-2032 (USD MILLION)
  • TABLE 206. EUROPE, MIDDLE EAST & AFRICA FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 207. EUROPE, MIDDLE EAST & AFRICA FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 208. EUROPE, MIDDLE EAST & AFRICA FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 209. EUROPE, MIDDLE EAST & AFRICA FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY UROLOGY, 2018-2032 (USD MILLION)
  • TABLE 210. EUROPE, MIDDLE EAST & AFRICA FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY WOMEN HEALTH, 2018-2032 (USD MILLION)
  • TABLE 211. EUROPE, MIDDLE EAST & AFRICA FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 212. EUROPE, MIDDLE EAST & AFRICA FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 213. EUROPE, MIDDLE EAST & AFRICA FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 214. EUROPE, MIDDLE EAST & AFRICA FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 215. EUROPE FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 216. EUROPE FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 217. EUROPE FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY MRI GUIDED, 2018-2032 (USD MILLION)
  • TABLE 218. EUROPE FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY ULTRASOUND GUIDED, 2018-2032 (USD MILLION)
  • TABLE 219. EUROPE FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY WORKFLOW, 2018-2032 (USD MILLION)
  • TABLE 220. EUROPE FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY OUTPATIENT, 2018-2032 (USD MILLION)
  • TABLE 221. EUROPE FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 222. EUROPE FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 223. EUROPE FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY ADULT, 2018-2032 (USD MILLION)
  • TABLE 224. EUROPE FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 225. EUROPE FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 226. EUROPE FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 227. EUROPE FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY UROLOGY, 2018-2032 (USD MILLION)
  • TABLE 228. EUROPE FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY WOMEN HEALTH, 2018-2032 (USD MILLION)
  • TABLE 229. EUROPE FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 230. EUROPE FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 231. EUROPE FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 232. EUROPE FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 233. MIDDLE EAST FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 234. MIDDLE EAST FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 235. MIDDLE EAST FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY MRI GUIDED, 2018-2032 (USD MILLION)
  • TABLE 236. MIDDLE EAST FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY ULTRASOUND GUIDED, 2018-2032 (USD MILLION)
  • TABLE 237. MIDDLE EAST FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY WORKFLOW, 2018-2032 (USD MILLION)
  • TABLE 238. MIDDLE EAST FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY OUTPATIENT, 2018-2032 (USD MILLION)
  • TABLE 239. MIDDLE EAST FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 240. MIDDLE EAST FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 241. MIDDLE EAST FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY ADULT, 2018-2032 (USD MILLION)
  • TABLE 242. MIDDLE EAST FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 243. MIDDLE EAST FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 244. MIDDLE EAST FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 245. MIDDLE EAST FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY UROLOGY, 2018-2032 (USD MILLION)
  • TABLE 246. MIDDLE EAST FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY WOMEN HEALTH, 2018-2032 (USD MILLION)
  • TABLE 247. MIDDLE EAST FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 248. MIDDLE EAST FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 249. MIDDLE EAST FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 250. MIDDLE EAST FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 251. AFRICA FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 252. AFRICA FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 253. AFRICA FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY MRI GUIDED, 2018-2032 (USD MILLION)
  • TABLE 254. AFRICA FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY ULTRASOUND GUIDED, 2018-2032 (USD MILLION)
  • TABLE 255. AFRICA FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY WORKFLOW, 2018-2032 (USD MILLION)
  • TABLE 256. AFRICA FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY OUTPATIENT, 2018-2032 (USD MILLION)
  • TABLE 257. AFRICA FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 258. AFRICA FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 259. AFRICA FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY ADULT, 2018-2032 (USD MILLION)
  • TABLE 260. AFRICA FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 261. AFRICA FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 262. AFRICA FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 263. AFRICA FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY UROLOGY, 2018-2032 (USD MILLION)
  • TABLE 264. AFRICA FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY WOMEN HEALTH, 2018-2032 (USD MILLION)
  • TABLE 265. AFRICA FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 266. AFRICA FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 267. AFRICA FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 268. AFRICA FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 269. ASIA-PACIFIC FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 270. ASIA-PACIFIC FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 271. ASIA-PACIFIC FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY MRI GUIDED, 2018-2032 (USD MILLION)
  • TABLE 272. ASIA-PACIFIC FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY ULTRASOUND GUIDED, 2018-2032 (USD MILLION)
  • TABLE 273. ASIA-PACIFIC FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY WORKFLOW, 2018-2032 (USD MILLION)
  • TABLE 274. ASIA-PACIFIC FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY OUTPATIENT, 2018-2032 (USD MILLION)
  • TABLE 275. ASIA-PACIFIC FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 276. ASIA-PACIFIC FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 277. ASIA-PACIFIC FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY ADULT, 2018-2032 (USD MILLION)
  • TABLE 278. ASIA-PACIFIC FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 279. ASIA-PACIFIC FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 280. ASIA-PACIFIC FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 281. ASIA-PACIFIC FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY UROLOGY, 2018-2032 (USD MILLION)
  • TABLE 282. ASIA-PACIFIC FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY WOMEN HEALTH, 2018-2032 (USD MILLION)
  • TABLE 283. ASIA-PACIFIC FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 284.